Page last updated: 2024-09-04

alpinetin and Ovarian Neoplasms

alpinetin has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guo, X; Hua, D; Shen, J; Zhao, X	1

Other Studies

1 other study(ies) available for alpinetin and Ovarian Neoplasms

Article	Year
Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling. Molecular medicine reports, 2018, Volume: 18, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Flavanones; G1 Phase; Humans; Matrix Metalloproteinases; Ovarian Neoplasms; S Phase; Signal Transduction; Spheroids, Cellular; STAT3 Transcription Factor; Tissue Inhibitor of Metalloproteinases; Tumor Stem Cell Assay	2018

Article

Year

Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling.

Molecular medicine reports, 2018, Volume: 18, Issue:4

Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Flavanones; G1 Phase; Humans; Matrix Metalloproteinases; Ovarian Neoplasms; S Phase; Signal Transduction; Spheroids, Cellular; STAT3 Transcription Factor; Tissue Inhibitor of Metalloproteinases; Tumor Stem Cell Assay

2018